dc.creator | Voucharas, C. | en |
dc.creator | Tagarakis, G. | en |
dc.creator | Lazou, A. | en |
dc.creator | Triposkiadis, F. | en |
dc.creator | Tsilimingas, N. | en |
dc.date.accessioned | 2015-11-23T10:54:01Z | |
dc.date.available | 2015-11-23T10:54:01Z | |
dc.date.issued | 2012 | |
dc.identifier | 10.1177/0003319711423529 | |
dc.identifier.issn | 0003-3197 | |
dc.identifier.uri | http://hdl.handle.net/11615/34629 | |
dc.description.abstract | We suggest a new, easily applicable way of myocardial hypertrophy induction in rats. Forty randomized age-matched male Wistar rats were divided into 2 groups of 20 each: a control group and an orally administered fludrocortisone/salt group. Myocardial hypertrophy was estimated by measuring body weight, heart-weight-to-body-weight ratio and ventricular free wall thickness. Moderate myocardial hypertrophy without heart failure was established in fludrocortisone/salt group in 4 weeks. Our method is effective and low cost, and it provides a model of hypertrophic heart. | en |
dc.source | Angiology | en |
dc.source.uri | <Go to ISI>://WOS:000305418100004 | |
dc.subject | heart | en |
dc.subject | hypertrophy | en |
dc.subject | hypertension | en |
dc.subject | corticoid | en |
dc.subject | fludrocortisone | en |
dc.subject | rat | en |
dc.subject | ADRENAL INSUFFICIENCY | en |
dc.subject | HYPERTENSION | en |
dc.subject | FAILURE | en |
dc.subject | MODELS | en |
dc.subject | ALDOSTERONE | en |
dc.subject | MYOCARDIUM | en |
dc.subject | DISEASE | en |
dc.subject | Peripheral Vascular Disease | en |
dc.title | Experimental Cardiac Hypertrophy Induced by Oral Administration of Mineralocorticoid and Saline in Rats | en |
dc.type | journalArticle | en |